Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
6 Years Into GLP-1s: What Maintenance Really Looks Like w/ Tara Rothenhoefer Tara Rothenhoefer was one of the earliest participants in a tirzepatide clinical trial, before the medication had a brand name
While the TRIUMPH-4 results are in, additional trials including TRIUMPH-1, TRIUMPH-2, and TRIUMPH-3 are ongoing or planned
Her expertise truly shows in her work
With that in mind its expected to submit the drug for regulatory approval towards the end of 2025, meaning it may be available as soon as 2026
As an important factor in the formation of ROS through enzymatic or non-enzymatic reactions, iron plays an essential role in sensitizing cells to ferroptosis
Small daily step
![Cardiovascular disease continuum-GLP-1 action. Adapted from [46]](https://www.researchgate.net/publication/357072789/figure/fig1/AS:1146405179654167@1650335702879/Cardiovascular-disease-continuum-GLP-1-action-Adapted-from-46.png)
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)